Radiopharmacy firm Medi-Physics has signed a deal with Fujisawato distribute its Adenoscan pharmacological stress agent, whichreceived Food and Drug Administration approval in May. Fujisawalicenses the agent from Medco Research. Medi-Physics, a
Radiopharmacy firm Medi-Physics has signed a deal with Fujisawato distribute its Adenoscan pharmacological stress agent, whichreceived Food and Drug Administration approval in May. Fujisawalicenses the agent from Medco Research.
Medi-Physics, a subsidiary of Amersham International, willdistribute Adenoscan through its network of 115 radiopharmacies.Medi-Physics, of Arlington Heights, IL, hopes to achieve synergiesbetween Adenoscan and its Myoview technetium-based cardiac imagingagent, which received an approvable letter from the Food and DrugAdministration last month (SCAN 8/2/95).
Emerging Perspectives on PSMA PET Radiotracers: An Interview with Kenneth J. Pienta, MD
April 24th 2024In a recent interview, Kenneth J. Pienta, M.D., discussed the impact of piflufolastat F18, current directions in research with other PSMA-targeted radiotracers and future possibilities for the role of PSMA PET in the imaging paradigm for prostate cancer.
Study Reveals Benefits of Photon-Counting CT for Assessing Acute Pulmonary Embolism
April 23rd 2024In comparison to energy-integrating detector CT for the workup of suspected acute pulmonary embolism, the use of photon-counting detector CT reduced radiation dosing by 48 percent, according to newly published research.